Skip to main content
    A

    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $21.12
    -0.11 (-0.52%)

    Market Cap: $7.40B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a latest price of $21.12 on Nov 17, 2026, 4.3% below its 52-week high of $22.07. Its price rose 81.4% over the past 12 months. The month-end price rose 7.0% over the 10 years through Oct 2026, a compound annual rate of 0.7%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $23.10 in Aug 2018 and its lowest $1.39 in Mar 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart AMRX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for AMRX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 16.6%, and over 6 months it rose 78.8%. The month-end price rose 455.8% over the 3 years through Oct 2026, a compound annual rate of 77.1%.

    PeriodChange
    1 month+9.1%
    3 months+16.6%
    6 months+78.8%
    12 months+81.4%
    12 months, with dividends+81.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+455.8%+77.1%
    5 years+291.8%+31.4%
    10 years+7.0%+0.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 205.0%, and its weakest was 2019, when it fell 64.4%.

    YearCloseChange
    2026 through Oct 2026$21.51+70.7%
    2025$12.60+59.1%
    2024$7.92+30.5%
    2023$6.07+205.0%
    2022$1.99-58.5%
    2021$4.79+4.8%
    2020$4.57-5.2%
    2019$4.82-64.4%
    2018$13.53-18.7%
    2017$16.65+25.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 6.3% above its 50-day average of $19.87 and 30.6% above its 200-day average of $16.17.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$21.12
    52-week high$22.07-4.3%
    52-week low$11.45+84.5%
    50-day average$19.87+6.3%
    200-day average$16.17+30.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 24.7%.

    MeasureValue
    1-year beta0.64
    Largest fall, 1 year-22.3%
    Largest fall, 3 years-24.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Amneal Pharmaceuticals, Inc. Class A Common Stock traded at 15.0x earnings at the end of 2025, against a 5-year median of 9.8x and a 10-year median of 10.8x.

    AMRX valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About AMRX

    What is AMRX's 1-year price change?

    Amneal Pharmaceuticals, Inc. Class A Common Stock's price rose 81.4% over the past 12 months. With dividends included, the 12-month total return was 81.4%.

    What is AMRX's 5-year price change?

    Amneal Pharmaceuticals, Inc. Class A Common Stock's month-end price rose 291.8% over the 5 years through Oct 2026, a compound annual rate of 31.4%. These figures leave out dividends.

    What is AMRX's 52-week high and low?

    Amneal Pharmaceuticals, Inc. Class A Common Stock's 52-week high is $22.07 and its 52-week low is $11.45. Its latest price of $21.12 on Nov 17, 2026 is 4.3% below the high.

    What is AMRX's beta?

    Amneal Pharmaceuticals, Inc. Class A Common Stock's 1-year beta against the S&P 500 is 0.64, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 22.3%.

    Is the AMRX chart free?

    Yes. Advanced Charting for AMRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.